US EQUITIES CLOSED CRYPTO 24/7
HALAL TRADING ROOM Sharia-screened signals
TERMINAL
OR

ORIOLA.HE

Stock Oriola Oyj
$0.89000

Nasdaq Helsinki · Healthcare · FI

Sharia status
NOT COMPLIANT
Per In-house ratio engine · assessed 2026-08-27
HTR non-permissible income 0.05%
🕌Open research, not a fatwa — verify with your own scholar.
Trade setup SEPARATE FROM SHARIAH
No trade setup shown — a stock that isn't cleanly Sharia-compliant never gets a bullish verdict here.

Oriola Oyj (ORIOLA.HE) is currently considered not halal (non-compliant), per In-house ratio engine (last assessed 2026-08-27). See the full ratio breakdown and business-activity screen below for the reasoning.

⚠️ Financial ratios are only half the screen. A company whose core business is in an excluded sector — weapons/defense, alcohol, gambling, conventional (interest-based) finance, tobacco, pork, or adult entertainment — is non-compliant even if every debt and income ratio passes. So passing ratios below don't override this verdict; check the business-activity screen for the reason.

Market & analysts
Price target
$0.99
+11.2% · 3 analysts
Institutional own.
12.9%
of shares
NON-COMPLIANT
Sharia compliance
0.05%
Non-permissible income — HTR, from filings (2025-12-31)
$0.99
Price target (+11.2%) · 3 analysts
12.9%
Institutional ownership

🕌 In-house Compliance Research

Computed from Yahoo Finance fundamentals (Tier-4 provider, no filing available), balance sheet as of 2025-12-31. ORIOLA.HE files no SEC reports, so these ratios come from the issuer's own published statements rather than XBRL.

Business activity: cleared (no excluded categories detected)

AAOIFI Fail

RatioValueThresholdResult
Interest-bearing debt 49.13% 30.00% Fail
Interest-bearing investments 91.41% 30.00% Fail
Non-permissible income 0.05% 5.00% Pass

Usmani Pass

RatioValueThresholdResult
Interest-bearing debt 8.65% 33.00% Pass
Interest-bearing investments 16.09% 33.00% Pass
Non-liquid assets 50.97% at least 20.00% Pass
Non-permissible income 0.05% 5.00% Pass

MSCI Fail

RatioValueThresholdResult
Interest-bearing debt 8.65% 33.33% Pass
Cash + interest-bearing securities 16.09% 33.33% Pass
Accounts receivable 49.03% 33.33% Fail
Non-permissible income 0.05% 5.00% Pass

FTSE Pass

RatioValueThresholdResult
Interest-bearing debt 8.65% 33.33% Pass
Cash + interest-bearing securities 16.09% 33.33% Pass
Accounts receivable 49.03% 50.00% Pass
Non-permissible income 0.05% 5.00% Pass

Dow Jones Islamic Market Fail

Scored against a trailing-average market cap (24-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 45.26% 33.00% Fail
Cash + interest-bearing securities 84.20% 33.00% Fail
Accounts receivable 172.44% 33.00% Fail
Non-permissible income 0.05% 5.00% Pass

S&P Shariah Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 47.10% 33.00% Fail
Cash + interest-bearing securities 87.64% 49.00% Fail
Accounts receivable 179.49% 49.00% Fail
Non-permissible income 0.05% 5.00% Pass

MSCI M-Series Fail

Scored against a trailing-average market cap (36-month), share-weighted by the issuer's own reported share counts — not today's market cap.

RatioValueThresholdResult
Interest-bearing debt 47.10% 33.33% Fail
Cash + interest-bearing securities 87.64% 33.33% Fail
Accounts receivable 267.13% 49.00% Fail
Non-permissible income 0.05% 5.00% Pass

Research only, not investment advice. Thresholds are each standard-setter's published limits; a ratio marked “at least” is a floor, not a ceiling.

1.221.131.050.960.882025-09-122026-03-132026-09-11

Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset

Support & Resistance
S3
0.88
S2
0.89
S1
0.89
PIVOT
0.90
R1
0.90
R2
0.90
R3
0.91

Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.

Price Forecast

7-day expected range
0.86 0.93
±3.89% from 0.89, made 2026-09-10 · resolves 2026-09-17
STRONG SELL
from 19 indicators
Not enough resolved predictions yet — 0 of 10 needed before we publish an accuracy figure. 22586 forecast(s) are currently open and will be scored automatically when their horizon expires.

The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.

Technical Summary

STRONG SELL
19 indicators
OscillatorsNEUTRAL
3 buy · 1 neutral · 3 sell
Moving averagesSTRONG SELL
0 buy · 0 neutral · 12 sell
Every indicator, and what it reads
IndicatorValueSignal
RSI (14)40.30NEUTRAL
Stochastic %K (14)6.25BUY
CCI (20)-149.22BUY
Williams %R (14)-93.75BUY
MACD (12,26,9)-0.00SELL
ROC (10)-1.66SELL
Momentum (10)-0.01SELL
EMA (10)0.90SELL
SMA (10)0.90SELL
EMA (20)0.90SELL
SMA (20)0.90SELL
EMA (30)0.90SELL
SMA (30)0.90SELL
EMA (50)0.91SELL
SMA (50)0.91SELL
EMA (100)0.92SELL
SMA (100)0.91SELL
EMA (200)0.99SELL
SMA (200)0.98SELL

Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.

About Oriola Oyj

Healthcare · Pharmaceutical Retailers

Oriola Oyj engages in the wholesale of pharmaceuticals and health products in Sweden, Finland, and internationally. The company distributes vitamins, food and food supplements, sports nutrients, wound care, beauty, and makeup related products; vaccines; and over-the-counter products. In addition, it provides pharmaceutical logistics; special licensed medicine importing, dose dispensing, and research pharmacy services; and commercial data, clinical trial, regulatory affairs and quality, medical and scientific affairs, market access and tenders, real world evidence, sales support, medical translation, pharmacovigilance and medical information, and patient support services. Further, the company provides advisory services. It serves pharmaceutical companies, pharmacies, veterinarians, hospitals, healthcare providers, special stores, retailers, and e-commerce companies. The company was founded in 1907 and is headquartered in Espoo, Finland.

oriola.com ↗

Background via Yahoo Finance — informational, not part of the verdict.

🕌 In-house Ratio Research — filings.xbrl.org ESEF XBRL

Research only, not the primary verdict above — SEC EDGAR (the source for the main in-house research card, if shown) has no data for this symbol, so this is computed from a real, country-specific filing instead. Business-activity screening isn't part of this check.

AAOIFI Standard 21 (% of market cap) — Fail
Debt ratio no data
Investments ratio 92.8% (< 30%)
Non permissible income ratio no data
Usmani (% of total assets) — Unverified
Debt ratio no data
Investments ratio 16.1% (< 33%)
Nonliquid assets ratio 83.9% (< 20%)
Non permissible income ratio no data
Net liquid assets -$0.6B (mkt cap $0.2B)

Based on the filing period ending 2025-12-31, figures in EUR.

SMC — Top Down

Not enough price history yet for a smart-money structure read on any timeframe.

Momentum & Volume

Peer Movement

Peer movement computing — it will appear here on its own.

Insider Activity (90d)

NO DATA   0 buys · 0 sells

COT Positioning — E-MINI S&P 500 - CHICAGO MERCANTILE EXCHANGE

NEUTRAL   report date 2026-09-08 · Asset managers net 912361 (-21819)

AI Summary

Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.

Tell us what's working, what's confusing, or what you want to see next — read by a real person, not a form that goes nowhere.